Cowen Reiterates Outperform Rating on Gilead Sciences (GILD), Warns Reward on TROPiCS-02 May Not be As Great
Tweet Send to a Friend
Cowen analyst Tyler Van Buren reiterated an Outperform rating and $75.00 price target on Gilead Sciences (NASDAQ: GILD). The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
